Finzati - Logo
COR logo

Cencora, Inc.

COR • Medical - Distribution
$330.95
▼ -6.27 (-1.86%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$64.19B
Growth
13.1%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 12.4%Positive free cash flow · 16.55Consistent free cash flow · 5/5Expensive earnings multiple · 38.98High debt level · 7.13
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$330.95
Change-1.86%
Shares Out193.94M
Market Cap$64.19B
Enterprise Value$73.09B
52W Range244.82 - 377.54
Beta0.57
P/E24.45
P/S0.19
P/B19.82
P/FCF15.81
EV/Sales0.22

Investment DNA

How strong this company looks for long-term investors

60
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
38/100
Growth Potential
Revenue and expansion
94/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Positive revenue growth · 12.4%Positive free cash flow · 16.55Consistent free cash flow · 5/5Expensive earnings multiple · 38.98High debt level · 7.13Weak liquidity · 0.9

Analyst view

Analyst sentiment and price target

COR
Analyst sentiment
Based on 46 analyst votes · 2026-09-05
85/100
Bullish
Bullish
33
Hold
12
Bearish
1
Price Target
2026-08-07
Low
$331.00
Mean
$362.17
Median
$350.00
High
$430.00

Company Overview

IPO: 4/4/1995
Industry: Medical - Distribution
P/B i: 19.82
Debt / Equity i: 7.13
Operating Margin: 1.14%
Net Margin: 0.48%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 7.13
Current Ratio: 0.90
Quick Ratio: 0.55
Status: Moderate

Warnings

  • High debt level
  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Tyler Lauren M
Transaction: 07/31/2026
BUY
Change
+97
Price
$311.34
Filing
08/04/2026
Type
BUY
Cooper Ellen
Transaction: 07/31/2026
BUY
Change
+97
Price
$311.34
Filing
08/04/2026
Type
BUY
NALLY DENNIS M
Transaction: 07/31/2026
BUY
Change
+113
Price
$311.34
Filing
08/04/2026
Type
BUY